DR. HENRY J DAVIS MD NPI 1174597538

NPI Details

DR. Henry J Davis, MD is a rheumatology internal medicine in Terre Haute, IN with 37 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Henry J Davis, MD NPI is 1174597538. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1988

The provider's business location address is:

2723 S 7TH ST
SUITE P
TERRE HAUTE, IN
ZIP 47802-562
Phone: (812) 232-8594
Fax: (812) 232-5565

The NPI 1174597538 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, infliximab-abda, biosimilar, (renflexis), 10 mg (HCPCS:Q5104)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Aspiration and/or injection of fluid from medium joint (HCPCS:20605)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• Injection of trigger points, 1-2 muscles (HCPCS:20552)

The enumeration date for this NPI number is 2/14/2006 and was last updated on 7/15/2014.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.